Frailty and Nerve Damage Go Hand-in-Hand in Dialysis Patients

Frailty is a syndrome of physical vulnerability and physiological decline that affects up to 73% of hemodialysis patients — far higher than in the general population. While frailty in end-stage renal disease (ESRD) has been linked to cognitive decline and poor cardiovascular outcomes, its relationship with peripheral nerve dysfunction had not been rigorously examined. This Turkish cross-sectional study set out to fill that gap by systematically characterizing the link between frailty severity and peripheral neuropathy in a maintenance hemodialysis cohort.

Seventy hemodialysis patients from three dialysis centers were enrolled and assessed using the validated Fried Frailty Phenotype, which categorizes individuals as non-frail (0 criteria), pre-frail (1–2), or frail (3–5) based on weight loss, exhaustion, low physical activity, reduced grip strength, and slow gait. All participants also underwent formal nerve conduction studies covering median, ulnar, peroneal, tibial, and sural nerves. Neuropathy severity was quantified with the Total Neuropathy Score (TNS), and ANCOVA was used to control for age and cardiovascular disease as confounders. Patients with vitamin B12 deficiency or non-diabetic neuropathy causes were excluded.

Patients classified as frail were significantly older and had higher rates of cardiovascular disease. Despite this, TNS rose sharply across frailty categories — median values of 3 (non-frail), 10.5 (pre-frail), and 13 (frail) — and frailty remained independently associated with TNS after adjustment (F(2,65)=6.415, p=0.003, partial η²=0.165). Electrophysiological parameters — including conduction velocities and action potential amplitudes — were significantly reduced in frail patients across multiple nerves. The Fried frailty score correlated strongly with TNS (rs=0.48, p<0.001). A subgroup analysis restricted to non-diabetic patients confirmed the relationship persisted independent of diabetes (p=0.024).

These findings point to a biologically meaningful overlap between frailty and uremic peripheral neuropathy. Uremic neuropathy typically presents as distal symmetric polyneuropathy, impairing sensory feedback, gait, and motor coordination — all functions that directly underpin the physical frailty criteria. The authors propose that shared pathophysiological pathways, including chronic inflammation, protein catabolism, sarcopenia, and neuroendocrine dysregulation, may drive both conditions simultaneously in ESRD patients.

Clinically, the findings argue for integrating peripheral nerve assessment into frailty evaluations for dialysis patients. Identifying neuropathy early could open targeted intervention windows — including optimized dialysis adequacy, physical rehabilitation, and nutritional support — to slow functional decline. The study is limited by its cross-sectional design, moderate sample size, and single-center EMG lab setting, meaning causality and generalizability remain uncertain.